Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 22-001776
NCT ID: NCT05108298
Sponsor Protocol Number: EAQ202
About this study
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Patient must be ≥ 18 years and ≤ 39 years of age at registration.
- Patient must have a histologically confirmed diagnosis of primary cancer of any stage within 12 weeks (84 days) at registration.
- Patient must have received, be currently receiving or planning to receive treatment for cancer, including surgery and/or chemotherapy and/or radiation therapy.
- Patient must have an ECOG performance status 0-3.
- Patient must have a life expectancy > 24 months.
- Patient must be able to complete questionnaires in English.
- Patient must have internet access through computer, tablet, or smartphone.
- Patient must have an email address.
- Patient must have a mobile phone able with text messaging capabilities.
- Patient must be able to accurately provide self-report data (e.g., per clinical judgment, cognitive function is intact). Patient must be able to provide informed consent.
- Patient must not have a recurrence or second primary cancer.
- Patient must not have basal cell skin carcinoma.
Eligibility last updated 2/17/22. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Zhaohui Jin, M.D.
Closed for enrollment
Cancer Center Clinical Trials Referral Office
Publications are currently not available